» Articles » PMID: 29473600

Osteoporosis for the Practicing Neurologist

Overview
Date 2018 Feb 24
PMID 29473600
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis is a common condition of impaired bone strength leading to fractures. A targeted history, physical exam, and blood work can help elucidate potentially reversible causes of low bone mass. In the neurology office, particular attention should be paid to the patient on glucocorticoids or antiepileptic medications, as these have distinct detrimental effects on bone. Patients can be risk-stratified by using the FRAX calculator, a tool that can help determine whether the patient is at sufficient risk of fracture to warrant pharmacologic therapy. Nonpharmacologic treatments such as calcium, vitamin D, and exercise should be discussed with the patient. The cornerstone of pharmacologic therapy has been treatment with bisphosphonates, but newer medications are available as well for the high-risk patient.

Citing Articles

Osteoporosis for the practicing neurologist.

Shubhakaran K, Jakhar Khichar R Neurol Clin Pract. 2018; 4(3):183-184.

PMID: 29473550 PMC: 5764509. DOI: 10.1212/01.CPJ.0000451407.84778.b0.

References
1.
Rittmaster R, Bolognese M, Ettinger M, Hanley D, Hodsman A, Kendler D . Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab. 2000; 85(6):2129-34. DOI: 10.1210/jcem.85.6.6614. View

2.
Carbone L, Johnson K, Robbins J, Larson J, Curb J, Watson K . Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res. 2009; 25(4):873-81. PMC: 3153335. DOI: 10.1359/jbmr.091027. View

3.
Nakken K, Tauboll E . Bone loss associated with use of antiepileptic drugs. Expert Opin Drug Saf. 2010; 9(4):561-71. DOI: 10.1517/14740331003636475. View

4.
Beniczky S, Viken J, Jensen L, Andersen N . Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure. 2012; 21(6):471-2. DOI: 10.1016/j.seizure.2012.04.002. View

5.
Cummings S, San Martin J, McClung M, Siris E, Eastell R, Reid I . Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009; 361(8):756-65. DOI: 10.1056/NEJMoa0809493. View